222 related articles for article (PubMed ID: 2446081)
1. Does acute serotonergic type-2 antagonism reduce blood pressure? Comparative effects of single doses of ritanserin and ketanserin in essential hypertension.
Hosie J; Stott DJ; Robertson JI; Ball SG
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S86-8. PubMed ID: 2446081
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat.
Persson B; Gradin K; Pettersson A; Hedner T
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S22-4. PubMed ID: 2459509
[TBL] [Abstract][Full Text] [Related]
3. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
4. The alpha-adrenergic receptor blocking effect of ketanserin and the interaction between alpha-adrenergic and S2-serotonergic receptor blockade.
van der Starre PJ; Reneman RS
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S54-61. PubMed ID: 2459516
[TBL] [Abstract][Full Text] [Related]
5. Experience with ketanserin and ritanserin in hypertensive patients.
Hedner T; Persson B
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S44-8. PubMed ID: 2459514
[TBL] [Abstract][Full Text] [Related]
6. Renal hemodynamic effects of ketanserin therapy in essential hypertension.
Ram CV; Gonzalez DG; Kaplan NM; Ralakis JM; Henderson JD; Lugo CE; Zachariah N
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S78-80. PubMed ID: 2446078
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of acute and chronic effects of ketanserin in the treatment of hypertension and hypothesis on a new mechanism of action].
Sechi LA
Ann Ital Med Int; 1990; 5(4 Pt 2):433-50. PubMed ID: 2102130
[TBL] [Abstract][Full Text] [Related]
8. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension].
Gambini G; Gradoli C; Proietti MG; Pinchi G; Fioroni E; Valori C
Clin Ter; 1989 Jul; 130(2):101-7. PubMed ID: 2529082
[TBL] [Abstract][Full Text] [Related]
9. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
[TBL] [Abstract][Full Text] [Related]
10. Ritanserin and serotonergic mechanisms in blood pressure and fluid regulation in sheep.
Nelson M; Coghlan JP; Denton DA; Tresham JJ; Whitworth JA; Scoggins BA
Clin Exp Pharmacol Physiol; 1987 Jul; 14(7):555-63. PubMed ID: 3124998
[TBL] [Abstract][Full Text] [Related]
11. Interference of ketanserin with baroreflex control of the circulation in the conscious spontaneously hypertensive rat.
Smits J; van Dorsten F; Struyker Boudier H
Drugs; 1988; 36 Suppl 1():55-60. PubMed ID: 3149239
[TBL] [Abstract][Full Text] [Related]
12. Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats.
Balasubramaniam G; Lee HS; Mah SC
J Pharmacol Exp Ther; 1993 Jan; 264(1):129-34. PubMed ID: 8093720
[TBL] [Abstract][Full Text] [Related]
13. [The effect of pharmacologic blockade of serotonin receptors (S2) on arterial pressure in rats with 2 forms of hereditary arterial hypertension].
Popova NK; Piianzin AI; Markel' AL
Farmakol Toksikol; 1989; 52(6):58-61. PubMed ID: 2516487
[TBL] [Abstract][Full Text] [Related]
14. Differences in vasodilating action between ketanserin, a 5-HT2-serotonergic receptor antagonist, and terazosin, an alpha 1-adrenoceptor antagonist, in anesthetized rabbits.
Ikeda K; Takata M; Tomoda F; Mikawa M; Iida H; Sasayama S
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S69-72. PubMed ID: 2446076
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure reduction and pharmacokinetics of ketanserin in hypertensive patients.
Hedner T; Pettersson A; Persson B
J Hypertens Suppl; 1986 Apr; 4(1):S91-3. PubMed ID: 2939221
[TBL] [Abstract][Full Text] [Related]
16. Specificity of the serotonergic antagonist ketanserin.
Stott DJ; Robertson JI; Ball SG
J Hypertens Suppl; 1985 Dec; 3(3):S191-3. PubMed ID: 2856702
[TBL] [Abstract][Full Text] [Related]
17. [Hemodynamic and humoral effects of 2 different doses of ketanserin in aged patients with hypertension].
Rizzoni D; Castellano M; Beschi M; Agabiti-Rosei E
Ann Ital Med Int; 1990; 5(4 Pt 2):489-96. PubMed ID: 2102136
[TBL] [Abstract][Full Text] [Related]
18. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
Andrén L; Svensson A; Dahlöf B; Eggertsen R; Hansson L
Acta Med Scand; 1983; 214(2):125-30. PubMed ID: 6353879
[TBL] [Abstract][Full Text] [Related]
19. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
[TBL] [Abstract][Full Text] [Related]
20. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats.
Docherty JR
J Pharmacol Exp Ther; 1989 Feb; 248(2):736-40. PubMed ID: 2537414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]